However, as GM-CSFR-βc-/- mutants rescue abnormalities in the setting of a Nf1-/- JMML model, we wondered if we might find a similar rescue in the neurofibroma model. This evidence concerns the gene CSF2RA and juvenile myelomonocytic leukemia.